| Daniel R Lemay, MD, PH D | |
|
8043 2nd St, Ste 105, Downey, CA 90241-3621 | |
| (562) 862-1134 | |
| (562) 861-9895 |
| Full Name | Daniel R Lemay |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 34 Years |
| Location | 8043 2nd St, Downey, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356347959 | NPI | - | NPPES |
| 00G742851 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | G74285 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Medical Center | Long beach, CA | Hospital |
| Orange County Global Medical Center | Santa ana, CA | Hospital |
| Lakewood Regional Medical Center | Lakewood, CA | Hospital |
| Saint Francis Medical Center | Lynwood, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Daniel R. Lemay Md Phd Inc | 8123035714 | 2 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
New research provides direct evidence that genetic variations in some African Americans with chronic kidney disease contribute to a more rapid decline in kidney function compared with white Americans.
A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. For patients with multiple tumors, that distinction could mean the difference between early stage cancer that may be cured by surgery and incurable late-stage disease.
During the U.N. General Assembly meeting in New York, British Prime Minister Gordon Brown on Wednesday is scheduled to announce that Britain is teaming up with Norway, the Netherlands and Australia to invest $1 billion to strengthen the health systems in developing countries, the Financial Times/NineMSN reports (Jack, 9/21).
› Verified 6 days ago
| Entity Name | Daniel R. Lemay Md Phd Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669511408 PECOS PAC ID: 8123035714 Enrollment ID: O20060307000270 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
New research provides direct evidence that genetic variations in some African Americans with chronic kidney disease contribute to a more rapid decline in kidney function compared with white Americans.
A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. For patients with multiple tumors, that distinction could mean the difference between early stage cancer that may be cured by surgery and incurable late-stage disease.
During the U.N. General Assembly meeting in New York, British Prime Minister Gordon Brown on Wednesday is scheduled to announce that Britain is teaming up with Norway, the Netherlands and Australia to invest $1 billion to strengthen the health systems in developing countries, the Financial Times/NineMSN reports (Jack, 9/21).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel R Lemay, MD, PH D 8043 2nd St, Ste 105, Downey, CA 90241-3621 Ph: (562) 862-1134 | Daniel R Lemay, MD, PH D 8043 2nd St, Ste 105, Downey, CA 90241-3621 Ph: (562) 862-1134 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
New research provides direct evidence that genetic variations in some African Americans with chronic kidney disease contribute to a more rapid decline in kidney function compared with white Americans.
A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. For patients with multiple tumors, that distinction could mean the difference between early stage cancer that may be cured by surgery and incurable late-stage disease.
During the U.N. General Assembly meeting in New York, British Prime Minister Gordon Brown on Wednesday is scheduled to announce that Britain is teaming up with Norway, the Netherlands and Australia to invest $1 billion to strengthen the health systems in developing countries, the Financial Times/NineMSN reports (Jack, 9/21).
› Verified 6 days ago
Duc H. Duong, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 8043 2nd St, Ste 105, Downey, CA 90241 Phone: 562-862-1134 Fax: 562-861-9895 | |
Mindy L Aisen, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7601 Imperial Hwy, Hb 117, Downey, CA 90242 Phone: 562-401-7161 Fax: 562-803-5623 |